Matches in Wikidata for { <http://www.wikidata.org/entity/Q34989826> ?p ?o ?g. }
- Q34989826 description "2009 nî lūn-bûn" @default.
- Q34989826 description "2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած" @default.
- Q34989826 description "2009 թվականի հուլիսին հրատարակված գիտական հոդված" @default.
- Q34989826 description "2009年の論文" @default.
- Q34989826 description "2009年論文" @default.
- Q34989826 description "2009年論文" @default.
- Q34989826 description "2009年論文" @default.
- Q34989826 description "2009年論文" @default.
- Q34989826 description "2009年論文" @default.
- Q34989826 description "2009年论文" @default.
- Q34989826 description "2009年论文" @default.
- Q34989826 description "2009年论文" @default.
- Q34989826 description "2009年论文" @default.
- Q34989826 description "2009年论文" @default.
- Q34989826 description "2009年论文" @default.
- Q34989826 description "2009년 논문" @default.
- Q34989826 description "article científic" @default.
- Q34989826 description "article scientific" @default.
- Q34989826 description "article scientifique (publié 2009)" @default.
- Q34989826 description "articol științific" @default.
- Q34989826 description "articolo scientifico" @default.
- Q34989826 description "artigo científico (publicado na 2009)" @default.
- Q34989826 description "artigo científico (publicado na 2009)" @default.
- Q34989826 description "artigo científico" @default.
- Q34989826 description "artikull shkencor" @default.
- Q34989826 description "artikulong pang-agham" @default.
- Q34989826 description "artykuł naukowy" @default.
- Q34989826 description "artículo científico publicado en 2009" @default.
- Q34989826 description "artículu científicu espublizáu en 2009" @default.
- Q34989826 description "bilimsel makale" @default.
- Q34989826 description "bài báo khoa học" @default.
- Q34989826 description "mokslinis straipsnis" @default.
- Q34989826 description "naučni članak" @default.
- Q34989826 description "scienca artikolo" @default.
- Q34989826 description "scientific article" @default.
- Q34989826 description "teaduslik artikkel" @default.
- Q34989826 description "tieteellinen artikkeli" @default.
- Q34989826 description "tudományos cikk" @default.
- Q34989826 description "vedecký článok" @default.
- Q34989826 description "vetenskaplig artikel" @default.
- Q34989826 description "videnskabelig artikel (udgivet 2009)" @default.
- Q34989826 description "vitenskapelig artikkel" @default.
- Q34989826 description "vitskapeleg artikkel" @default.
- Q34989826 description "vědecký článek" @default.
- Q34989826 description "wetenschappelijk artikel" @default.
- Q34989826 description "wissenschaftlicher Artikel" @default.
- Q34989826 description "επιστημονικό άρθρο" @default.
- Q34989826 description "мақолаи илмӣ" @default.
- Q34989826 description "мақолаи илмӣ" @default.
- Q34989826 description "наукова стаття, опублікована в липні 2009" @default.
- Q34989826 description "научна статия" @default.
- Q34989826 description "научная статья" @default.
- Q34989826 description "научни чланак" @default.
- Q34989826 description "научни чланак" @default.
- Q34989826 description "מאמר מדעי" @default.
- Q34989826 description "سائنسی مضمون" @default.
- Q34989826 description "مقالة علمية" @default.
- Q34989826 description "مقالهٔ علمی" @default.
- Q34989826 description "২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34989826 description "บทความทางวิทยาศาสตร์" @default.
- Q34989826 description "სამეცნიერო სტატია" @default.
- Q34989826 name "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 name "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 name "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 type Item @default.
- Q34989826 label "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 label "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 label "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 prefLabel "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 prefLabel "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 prefLabel "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.
- Q34989826 P1433 Q34989826-3057C321-8BA6-4992-BC88-4AAD3C6E916F @default.
- Q34989826 P1476 Q34989826-62C07387-F315-4DAD-8453-0BA35E512347 @default.
- Q34989826 P2093 Q34989826-040E9890-53A0-4D3C-8EE0-BEB756879AFC @default.
- Q34989826 P2093 Q34989826-142F0F67-B70B-4612-84CD-2D456E0C73C9 @default.
- Q34989826 P2093 Q34989826-1ECF04C2-D64D-451D-9A2D-491202DB42CA @default.
- Q34989826 P2093 Q34989826-2C04BDE2-2E99-4F8E-81F1-088D3A2CD989 @default.
- Q34989826 P2093 Q34989826-5096655D-C8FF-4B9A-9981-A5C70630A793 @default.
- Q34989826 P2093 Q34989826-5C5F9B4C-07EB-4FE8-B7FD-AD6EF4BD28D8 @default.
- Q34989826 P2093 Q34989826-A6A492F1-99EB-45C6-8A01-DD125E6C0574 @default.
- Q34989826 P2093 Q34989826-A959EB80-1399-420D-BB62-62A1DBCA6EEF @default.
- Q34989826 P2093 Q34989826-B3AC12C8-6A8C-473E-B670-E5F948F21C32 @default.
- Q34989826 P2093 Q34989826-ED35C9FB-041F-49C2-B111-9592A72CD01D @default.
- Q34989826 P2093 Q34989826-EE8BE918-85BF-4F98-BC67-356FE26D6D68 @default.
- Q34989826 P304 Q34989826-28215ECD-1722-4608-B008-D6A62A5801C1 @default.
- Q34989826 P31 Q34989826-A1BC815D-346C-415C-8D7E-760B30ED76E5 @default.
- Q34989826 P356 Q34989826-F6DDC83A-88B2-4BEC-A4CB-8D41A04E9C64 @default.
- Q34989826 P433 Q34989826-CBDE7A3B-02A5-4741-A58F-2A8DE00F1E82 @default.
- Q34989826 P478 Q34989826-AA9E7686-1DCF-4342-9DE3-451F20BC68D7 @default.
- Q34989826 P50 Q34989826-5461AC66-4596-4F3A-AF55-F7009269C93D @default.
- Q34989826 P577 Q34989826-5F4B4705-8467-4D2C-AFD9-6B77EDC217A4 @default.
- Q34989826 P5875 Q34989826-6490ECD1-D3AF-4683-B98D-BCAE452782C4 @default.
- Q34989826 P698 Q34989826-6A6DA08E-F7BF-43CB-9BD7-1A0510C82E34 @default.
- Q34989826 P921 Q34989826-7BBAED17-763C-430F-BA99-A1BF57F61F51 @default.
- Q34989826 P921 Q34989826-C2477E89-DF8E-4F89-BCAF-3728668A1BE0 @default.
- Q34989826 P921 Q34989826-F59173F6-9EA1-4E61-9402-772E782722DA @default.
- Q34989826 P356 ART.24567 @default.
- Q34989826 P698 19565475 @default.
- Q34989826 P1433 Q4797636 @default.
- Q34989826 P1476 "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" @default.